Difference between revisions of "Ephrin A"

From MyMediaWiki
Jump to: navigation, search
m
m
 
Line 1: Line 1:
 
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
 
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
! {{infobox header}}| '''{{PAGENAME}}'''  
+
! {infobox header}| '''{{PAGENAME}}'''  
 
|-
 
|-
 
| Substrate peptide name
 
| Substrate peptide name
Line 50: Line 50:
 
TG2 cross-linking of ephrin increases the migration of HeLa cells endogenously expressing Eph A2.
 
TG2 cross-linking of ephrin increases the migration of HeLa cells endogenously expressing Eph A2.
 
|-
 
|-
| {{infobox header}} |  
+
| {infobox header} |  
 
|-
 
|-
 
|}
 
|}
  
 
[[Category:Tissue transglutaminase|*]]
 
[[Category:Tissue transglutaminase|*]]

Latest revision as of 11:35, 10 March 2015

Ephrin A
Substrate peptide name Ephrin A
Synonyms EPH-related receptor tyrosine kinase ligand
Determination type In vitro - Ephrin A1

In vivo - Ephrin A5

Source Homo sapiens

Mus musculus

Subcellular localization Plasma membrane

Extracellular space

Swissprot ID P20827

P52803

Reactive glutamines Not determined yet
Reactive lysines Not determined yet
Substrate sequence
Structure No available crystal structure
Surface accessibility
Disorder prediction IUPred
Reference PMID:17707797
Notes Tissue transglutaminase clusters soluble A-type ephrins to promote Eph receptor activity

TG2 cross-linking of ephrin increases the migration of HeLa cells endogenously expressing Eph A2.